Ponatinib medication guide: on an empty stomach or with meals? Dose adjustment and discontinuation of medication
The administration of Ponatinib should follow the principle of fasting, and dosage adjustments should be graded according to the severity of adverse reactions. In specific cases, permanent discontinuation of the medication is required. The following provides a detailed explanation of medication standards from three aspects: medication methods, dosage adjustments, and discontinuation criteria.
1. Medication method
Punitinib should be taken on an empty stomach and administered 1 hour before or 2 hours after meals. Avoid taking it with a high-fat diet to prevent fluctuations in blood drug concentration from affecting the therapeutic effect. Take medication at a fixed time every day to ensure treatment stability.
2. Dose adjustment
(1) Conventional adjustment plan
The initial dose is 45mg once daily. When grade 2 or above adverse reactions occur, the first dose should be reduced to 30mg/day, and the second dose should be reduced to 15mg/day. If it still cannot be tolerated, the medication needs to be permanently discontinued.
(2) Specific toxicity adjustment
Arterial thrombotic events require immediate discontinuation of medication. Suspend medication for level 3 non hematological toxicity and reduce dosage after recovery; Level 4 toxicity: permanently discontinued. Patients with pancreatitis need to pause and assess the risk of restarting.
(3) Combination therapy adjustment
Reduce the dosage to 30mg/day when combined with potent CYP3A4 inhibitors; When used in combination with inducers, the dosage needs to be increased. Close monitoring of adverse reactions is required after adjustment.
3. Discontinuation criteria
The occurrence of fatal arterial thrombosis, grade 4 hepatotoxicity, or intolerable hematological toxicity requires permanent discontinuation of the medication. During the treatment period, evaluate the disease status every 3 months and consider changing plans when it progresses.
(1) Indications for drug suspension
Grade 3 hematological toxicity should be temporarily suspended if it persists for more than 2 weeks. Grade 2 heart failure, Grade 3 rash, or abnormal liver function require interruption of treatment until recovery to Grade 1.
(2) Restart treatment conditions
After the toxicity is reduced to ≤ level 1, medication can be gradually resumed. We need to start with lower doses and increase monitoring frequency. Recurrent toxicity requires permanent discontinuation of medication.
Disclaimer：《Ponatinib medication guide: on an empty stomach or with meals? Dose adjustment and discontinuation of medication》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！